Kilroy Conor 4
4 · IRONWOOD PHARMACEUTICALS INC · Filed Nov 10, 2020
Insider Transaction Report
Form 4
Kilroy Conor
SVP, GC & Secretary
Transactions
- Sale
Class A Common Stock
2020-11-09$10.92/sh−237$2,588→ 128,833 total - Sale
Class A Common Stock
2020-11-09$10.92/sh−599$6,541→ 129,070 total
Footnotes (3)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on December 16, 2016.
- [F2]The reporting person acquired 748 shares of Class A common stock under the issuer's employee stock purchase plan on June 30, 2020.
- [F3]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on December 15, 2017.